James R. Empfield is VP at Xenon Pharmaceuticals Inc. (XENE). They have made 3 open-market trades across 1 company since 2017, most recently 2022-08-12.
CIK 0001665430
1 open-market purchase totalling $25K since 2017, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XENE | 31,875 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2022-08-16 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.